CHRU - Centre hospitalier universitaire régional universitaire de Besançon

Type: Evaluation report on University Hospitals/Cancer Centers

Evaluation campaign: 2015-2016 (group B) - Published on: 24/08/2017

Institution(s) concerned: Centre hospitalier régional et universitaire de Besancon - CHRU Besancon

Disciplinary research field: Life and Earth Sciences (SVE) ; SVE2 Cellular Biology, Imaging, Molecular Biology, Biochemistry, Genomics, Systemic Biology, Development, Structural Biology ; SVE3 Microbiology, Virology, Immunity

Scientific field(s): 5 - Biologie, medecine et santé

ERC panel(s): LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics; LS6 Immunity and infection: immunobiology, aetiology of immune disorders, microbiology, virology, parasitology, global and other infectious diseases, population dynamics of infectious diseases, veterinary medicine ; LS9 Applied life sciences and biotechnology: agricultural, animal, fishery, forestry and food sciences ; LS7 Diagnostic tools, therapies and public health: aetiology, diagnosis and treatment of disease, public health, epidemiology, pharmacology, clinical medicine, regenerative medicine, medical ethics ; LS5 Neurosciences and neural disorders: neurobiology, neuroanatomy, neurophysiology, neurochemistry, neuropharmacology, neuroimaging, systems neuroscience, neurological disorders, psychiatry

Keywords: Biothérapies; Maladies inflammatoires ; Cancérologie ; Immunothérapie; transplantation ; Neurosciences ; Innovations technologiques ; Dispositifs médicaux ; Biotechnologies ; Risques et infectiologie ; risques neuro-cardio-vasculaires ; risques et technologies; vulnérabilité ; santé publique ; économie de la santé